292 related articles for article (PubMed ID: 25586062)
21. The metalloprotease-disintegrin ADAM8 contributes to temozolomide chemoresistance and enhanced invasiveness of human glioblastoma cells.
Dong F; Eibach M; Bartsch JW; Dolga AM; Schlomann U; Conrad C; Schieber S; Schilling O; Biniossek ML; Culmsee C; Strik H; Koller G; Carl B; Nimsky C
Neuro Oncol; 2015 Nov; 17(11):1474-85. PubMed ID: 25825051
[TBL] [Abstract][Full Text] [Related]
22. miR-20a mediates temozolomide-resistance in glioblastoma cells via negatively regulating LRIG1 expression.
Wei J; Qi X; Zhan Q; Zhou D; Yan Q; Wang Y; Mo L; Wan Y; Xie D; Xie J; Yang S
Biomed Pharmacother; 2015 Apr; 71():112-8. PubMed ID: 25960225
[TBL] [Abstract][Full Text] [Related]
23. Altered expression of splicing factor, heterogeneous nuclear ribonucleoprotein A2/B1, in mouse lung neoplasia.
Peebles KA; Dwyer-Nield LD; Malkinson AM
Mol Carcinog; 2007 Nov; 46(11):887-900. PubMed ID: 17477362
[TBL] [Abstract][Full Text] [Related]
24. MiR-223/PAX6 Axis Regulates Glioblastoma Stem Cell Proliferation and the Chemo Resistance to TMZ via Regulating PI3K/Akt Pathway.
Huang BS; Luo QZ; Han Y; Huang D; Tang QP; Wu LX
J Cell Biochem; 2017 Oct; 118(10):3452-3461. PubMed ID: 28332226
[TBL] [Abstract][Full Text] [Related]
25. hnRNP A2/B1 modulates epithelial-mesenchymal transition in lung cancer cell lines.
Tauler J; Zudaire E; Liu H; Shih J; Mulshine JL
Cancer Res; 2010 Sep; 70(18):7137-47. PubMed ID: 20807810
[TBL] [Abstract][Full Text] [Related]
26. Downstream targets of heterogeneous nuclear ribonucleoprotein A2 mediate cell proliferation.
He Y; Rothnagel JA; Epis MR; Leedman PJ; Smith R
Mol Carcinog; 2009 Feb; 48(2):167-79. PubMed ID: 18680105
[TBL] [Abstract][Full Text] [Related]
27. Heterogeneous nuclear ribonucleoprotein B1 as a new marker of early detection for human lung cancers.
Sueoka E; Goto Y; Sueoka N; Kai Y; Kozu T; Fujiki H
Cancer Res; 1999 Apr; 59(7):1404-7. PubMed ID: 10197602
[TBL] [Abstract][Full Text] [Related]
28. MALAT1 is a prognostic factor in glioblastoma multiforme and induces chemoresistance to temozolomide through suppressing miR-203 and promoting thymidylate synthase expression.
Chen W; Xu XK; Li JL; Kong KK; Li H; Chen C; He J; Wang F; Li P; Ge XS; Li FC
Oncotarget; 2017 Apr; 8(14):22783-22799. PubMed ID: 28187000
[TBL] [Abstract][Full Text] [Related]
29. Prognostic and diagnostic relevance of hnRNP A2/B1, hnRNP B1 and S100 A2 in non-small cell lung cancer.
Zech VF; Dlaska M; Tzankov A; Hilbe W
Cancer Detect Prev; 2006; 30(5):395-402. PubMed ID: 17067748
[TBL] [Abstract][Full Text] [Related]
30. Downregulation of HIF-1a sensitizes U251 glioma cells to the temozolomide (TMZ) treatment.
Tang JH; Ma ZX; Huang GH; Xu QF; Xiang Y; Li N; Sidlauskas K; Zhang EE; Lv SQ
Exp Cell Res; 2016 May; 343(2):148-158. PubMed ID: 27090014
[TBL] [Abstract][Full Text] [Related]
31. LRIG1 dictates the chemo-sensitivity of temozolomide (TMZ) in U251 glioblastoma cells via down-regulation of EGFR/topoisomerase-2/Bcl-2.
Qi XC; Xie DJ; Yan QF; Wang YR; Zhu YX; Qian C; Yang SX
Biochem Biophys Res Commun; 2013 Aug; 437(4):565-72. PubMed ID: 23850692
[TBL] [Abstract][Full Text] [Related]
32. The localization of hnRNP A2/B1 in nuclear matrix and the aberrant expression during the RA-induced differentiation of human neuroblastoma SK-N-SH cells.
Liang Y; Shi SL; Li QF; Chen LY; Jing GJ; Tan GW; Wang SY; Wu FY
J Cell Biochem; 2011 Jul; 112(7):1722-9. PubMed ID: 21321999
[TBL] [Abstract][Full Text] [Related]
33. hnRNP A2/B1 interacts with influenza A viral protein NS1 and inhibits virus replication potentially through suppressing NS1 RNA/protein levels and NS1 mRNA nuclear export.
Wang Y; Zhou J; Du Y
Virology; 2014 Jan; 449():53-61. PubMed ID: 24418537
[TBL] [Abstract][Full Text] [Related]
34. TROY (TNFRSF19) promotes glioblastoma survival signaling and therapeutic resistance.
Loftus JC; Dhruv H; Tuncali S; Kloss J; Yang Z; Schumacher CA; Cao B; Williams BO; Eschbacher JM; Ross JT; Tran NL
Mol Cancer Res; 2013 Aug; 11(8):865-74. PubMed ID: 23699535
[TBL] [Abstract][Full Text] [Related]
35. Heterogeneous nuclear ribonucleoprotein A2/B1 is a negative regulator of human breast cancer metastasis by maintaining the balance of multiple genes and pathways.
Liu Y; Li H; Liu F; Gao LB; Han R; Chen C; Ding X; Li S; Lu K; Yang L; Tian HM; Chen BB; Li X; Xu DH; Deng XL; Shi SL
EBioMedicine; 2020 Jan; 51():102583. PubMed ID: 31901866
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of EZH2 reverses chemotherapeutic drug TMZ chemosensitivity in glioblastoma.
Fan TY; Wang H; Xiang P; Liu YW; Li HZ; Lei BX; Yu M; Qi ST
Int J Clin Exp Pathol; 2014; 7(10):6662-70. PubMed ID: 25400745
[TBL] [Abstract][Full Text] [Related]
37. APE1/REF-1 down-regulation enhances the cytotoxic effects of temozolomide in a resistant glioblastoma cell line.
Montaldi AP; Godoy PR; Sakamoto-Hojo ET
Mutat Res Genet Toxicol Environ Mutagen; 2015 Nov; 793():19-29. PubMed ID: 26520369
[TBL] [Abstract][Full Text] [Related]
38. Metformin treatment reduces temozolomide resistance of glioblastoma cells.
Yang SH; Li S; Lu G; Xue H; Kim DH; Zhu JJ; Liu Y
Oncotarget; 2016 Nov; 7(48):78787-78803. PubMed ID: 27791206
[TBL] [Abstract][Full Text] [Related]
39. Characterizing the molecular mechanisms of acquired temozolomide resistance in the U251 glioblastoma cell line by protein microarray.
Lin J; Zuo J; Cui Y; Song C; Wu X; Feng H; Li J; Li S; Xu Q; Wei W; Qiu G; He H
Oncol Rep; 2018 May; 39(5):2333-2341. PubMed ID: 29565460
[TBL] [Abstract][Full Text] [Related]
40. hnRNP B1 protein may be a possible prognostic factor in squamous cell carcinoma of the lung.
Wu S; Sato M; Endo C; Sakurada A; Dong B; Aikawa H; Chen Y; Okada Y; Matsumura Y; Sueoka E; Kondo T
Lung Cancer; 2003 Aug; 41(2):179-86. PubMed ID: 12871781
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
